Neuroimmunology: Are naturally occurring anti-NMDAR autoantibodies pathogenic?

[1]  J. Krauss,et al.  Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model , 2018, Molecular Psychiatry.

[2]  K. Sakimura,et al.  121. Differences Between Auto-Antibody Titres in Cerebrospinal Fluids and Sera of Patients With Anti-N-methyl-D Receptor Encephalitis. , 2017 .

[3]  N. Kato,et al.  Induction of Memory Deficit in Mice with Chronic Exposure to Cerebrospinal Fluid from Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis. , 2015, The Tohoku journal of experimental medicine.

[4]  N. Burnashev,et al.  NMDA receptor subunit mutations in neurodevelopmental disorders. , 2015, Current opinion in pharmacology.

[5]  G. Spalletta,et al.  Seroprevalence of autoantibodies against brain antigens in health and disease , 2014, Annals of neurology.

[6]  R. Balice-Gordon,et al.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study , 2014, The Lancet Neurology.

[7]  Robert G. Nagele,et al.  Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease , 2013, PloS one.

[8]  R. Balice-Gordon,et al.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[9]  M. Constantine‐Paton,et al.  Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal , 2004, Trends in Neurosciences.

[10]  R. Balice-Gordon,et al.  Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. , 2015, Brain : a journal of neurology.